The Food and Drug Administration of the USA has approved Zepbound for curing sleep Apnea. This drug is used to treat severe obstructive sleep apnea or OSA. This drug can be given to adults who deal with obesity. This drug can be used for adults with a proper diet plan and exercise. In this article, we will discuss more about the FDA’s approval of drugs to cure obstructive sleep apnea.
Sally Seymour who is the MD and director of the division of pulmonology in the FDA Center for Drug Evaluation has stated that the FDA‘s approval of the drug is the first drug treatment option for some patients with OSA.
Cause of Obstructive Sleep Apnea
Obstructive Sleep Apnea or OSA happens when a block occurs upper airway of a person. This block causes pauses in the breathing cycle of a person when they sleep. OSA commonly affects people who are obese or overweight. However obstructive Sleep Apnea can affect any individual.
Also read: Christmas Market Attack in Germany: 2 Dead, 68 Injured
About approval of Zepbound
The drug Zepbound is approved by the FDA for adults who have moderate to severe OSA. The approval of the drug is based on a study conducted on 469 adults who do not have type 2 diabetes. One of the studies had adults who use positive airway pressure or PAP and the other study included individuals who didn’t want to use PAP. Positive airway pressure is the care given to patients who suffer from obstructive sleep apnea. In both studies conducted the adults received 10 to 15g of Zepbound once in a week for a year. The efficiency of the treatment was measured in the last week or the 52nd week. After the 52nd week, the adults who participated in the study had a significant reduction in the events of apnea. The adults who received Zepbound also had a body weight loss at the end of 52 weeks.
Side effects of the drug Zepbound
The drug Zepbound can cause several side effects such as allergic reactions, pain, discomfort, nausea, diarrhea, vomiting, and constipation. The drug cannot be used in patients who have a family history of thyroid cancer. Also, the drug Zepboind cannot be used in patients who have an allergic reaction to trizepatide. Trizepatide is the active ingredient of Zepbound. Patients who are suffering from gallbladder stones or pancreatitis should consult with their Healthcare providers before taking the drug Zepbound.
Conclusion
The Food and Drug Administration(FDA) approved the drug Zepbound for the curing of Obstructive sleep apnea. In this article, we have mentioned about the drug Zepbound. We have also discussed the study conducted to approve the drug for patients suffering from OSA.
